4
Changes in Ownership
BioAge Labs, Inc. Filed Acc 0001415889-25-004867
Options or other derivatives
- Chief Medical Officer acquired 200,000 shares (grant or award)
From the SEC's structured data for this filing
BioAge Labs, Inc. Filed Acc 0001415889-25-004867
Options or other derivatives
From the SEC's structured data for this filing
Connection lost
Reconnecting…
Cite Filings isn't responding
Reconnecting…